Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00527722 · ClinicalTrials.gov registry record · Phase 2
Evaluation of the Bio-Seal Biopsy Track Plug
A Phase 2 study, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 77
- Enrollment target
NCT00527722: Completed Phase 2 study, sponsored by M.D. Anderson Cancer Center.
NCT00527722 is a Phase 2 study that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 77 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00527722, a Phase 2 study, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 77 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate safety and effectiveness of the Bio-Seal Biopsy Track Plug in a clinical setting for use in lung biopsy procedures to reduce the rate of air leaks, commonly associated with the procedure. The Bio-Seal System is cleared in the U.S. with an indication for use as a lung biopsy site marker.
Interventions
- DEVICE Bio-Seal Track Plug
- OTHER No lung plug
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 77 participants |
| Start Date | 2005-09 |
| Est. Completion | 2008-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00527722
The ClinicalTrials.gov registry entry for NCT00527722 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 77 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Bio-Seal Track Plug is the first listed.
NCT00527722 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00527722 about?
NCT00527722 is a clinical study titled "Evaluation of the Bio-Seal Biopsy Track Plug". The purpose of this study is to demonstrate safety and effectiveness of the Bio-Seal Biopsy Track Plug in a clinical setting for use in lung biopsy procedures to reduce the rate of air leaks, commonly associated with the procedure. The Bio-Seal System is cleared in the U.S. with an indication for us...
What is the current status of trial NCT00527722?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 77 participants. The study started on 2005-09. Estimated completion is 2008-12.
What interventions are being tested in trial NCT00527722?
The interventions under investigation include: Bio-Seal Track Plug (DEVICE), No lung plug (OTHER).
Who is sponsoring clinical trial NCT00527722?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.